Apoha Ltd (Apoha Limited)
Executive Overview
Apoha Ltd is a pioneering deep-tech company based in London, United Kingdom, that has introduced a new paradigm in computing known as Sensory Intelligence. Founded in 2021 by Dr. Shamit Shrivastava (a former postdoctoral researcher at the University of Oxford and inventor of the core technology) and Anshika Srivastava (a former Executive Director at Goldman Sachs), the company is building what it calls the "Liquid Brain."
Unlike traditional computers that rely on silicon-based binary logic, Apoha's technology utilizes excitable liquids to mimic the biophysical properties and behavioral intelligence of a neuron. This "liquid computer" is designed to "feel," "taste," and "smell" molecules at a level of resolution previously inaccessible to scientific instruments. By recreating the physics of sensation, Apoha aims to revolutionize drug discovery, material design, and food systems, providing a bridge between digital models and physical reality.
Continue…
The Core Technology: The Liquid Brain
The foundation of Apoha's innovation lies in a thermodynamic perspective of biological systems. The technology is based on the discovery that nonlinear acoustic pulses; specifically Lucassen waves can travel along lipid interfaces near phase transitions. These waves exhibit the same thermodynamic efficiency and properties as neuronal signals.
1. Neuromorphic Fluid-Based Computing
Apoha has developed a platform where excitable fluids act as both the sensor and the processor. When these fluids are exposed to a chemical or a complex mixture, they react with neuron-like activity. This allows the system to:
* Capture Sensory Fingerprints: Map the unique biophysical properties of complex molecules and formulations.
* Detect Subtle Differences: Reveal how molecules bend, ripple, float, and dissolve?data points that are often lost in traditional digital assays.
* Scale Information Processing: Perform complex biophysical classifications in minutes rather than months, using as little as 10?g of a sample.
2. Physical Anchoring of Machines
The company describes its mission as "anchoring machines into physical reality." By providing machines with sensory data rather than just "digital shadows" or simulations, Apoha enables a more accurate understanding of how new medicines or materials will behave in the real world under stress or in motion.
Products and Services
1. The Liquid Brain Platform
The primary product offered by Apoha is a foundational sensory intelligence platform. It is a high-performance scientific machine that integrates proprietary hardware with advanced neuromorphic algorithms.
* Biophysical Classification: The platform solves difficult classification problems by comparing the sensory data of new molecules against known benchmarks.
* Molecular Analysis: It provides hidden data regarding molecular behavior under various conditions (e.g., stress-testing, mixture interactions).
* SaaS Integration: The hardware works in tandem with software that interprets the "liquid signals" and translates them into actionable insights for researchers and developers.
2. Drug Discovery and Biopharma Solutions
Apoha provides specialized services for the pharmaceutical industry, with a focus on the "hit-to-lead" phase of drug development.
* Antibody Developability Screening: One of the company's most significant service areas is the high-throughput screening of antibodies. The platform ranks antibodies based on their developability potential by analyzing their underlying biophysical properties, directly addressing the rising costs and high failure rates of R&D.
* Small Molecule Behavior: The platform is used to predict how new drugs will interact with biological interfaces, helping to identify safe and effective candidates earlier in the lifecycle.
3. Material Design and Agri-Food Systems
The company's sensory intelligence is applied to the design of resilient food systems and novel materials.
* Ingredient Analysis: Helping companies understand the "taste" and "texture" of new ingredients at a molecular level.
* Material Stress-Testing: Analyzing how complex formulations react to environmental stressors, ensuring the durability and safety of new materials.
Strategic Growth and Partnerships
Apoha has garnered significant attention within the deep-tech and venture capital communities. As of late 2025, the company has raised approximately $10.3 million in funding. A notable $8.45 million Seed Round in 2023 was led by Redalpine and supported by Seedcamp, Bachmann & Welser Capital, and Plug and Play Tech Center.
Notable Milestones:
- Intel Ignite Participation: Apoha was selected for the prestigious Intel Ignite accelerator program, which focuses on supporting the most disruptive deep-tech startups.
- Innovate UK Support: The company has received grants and support from Innovate UK to apply its neuromorphic sensing technology to the challenge of antibody screening, aligning with the UK's broader Innovation Strategy to improve pharmaceutical R&D efficiency.
- Patented Innovation: Apoha maintains a robust intellectual property portfolio, with nearly 50 patent applications and grants covering its hardware designs and neuromorphic algorithms.
Operational Location
Apoha Limited is headquartered in London, United Kingdom. The company maintains a multidisciplinary team of scientists, product experts, and engineers focused on the intersection of physics, biology, and computing.
